510(k) Report

510(k) · Cleared

Cleared

AVERT Contrast Modulation System

K151300510(k) TraditionalCleared Oct 15, 2015153-day reviewClass II21 CFR 870.1650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Osprey Medical, Inc. · DXT Injector And Syringe, Angiographic

Cleared on Oct 15, 2015 as substantially equivalent to K140425 (Osprey Medical, Inc., 2014) and 1 other predicate after a 153-day review. Its family tree reaches back 7 generations to 1982. 8 later devices descend from it.

Decided
Oct 15, 2015
Review
153 days
Class
Class II
Product code
DXT
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K822536 (1982). 14 ancestors in all. 8 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2011: 1 other ancestor2005: 1 other ancestor2000: 2 other ancestors1999: 1 other ancestor1996: 1 other ancestor1991: 1 other ancestor2016: 2 descendants cleared2018: 2 descendants cleared2017: 3 descendants cleared2019: 1 descendant clearedK822536 · MARK V · Medrad, Inc. · 1982K963982 · Acist Angiographic Injector · Invasatec · 1997K984058 · Acist Injector System, Model CL100 H · Acist Medical Systems · 1999K991103 · Modification to Acist CL 100H · Acist Medical Systems · 2000 · recalledK131478 · Contrast Conservation System · Osprey Medical, Inc. · 2013K140425 · Contrast Modulation System · Osprey Medical, Inc. · 2014K150485 · AVERT Contrast Modulation System · Osprey Medical, Inc. · 201519801990200020102020
Other ancestors, by generationDescendants, by generation 3 generations back: 4 other ancestors4 generations back: 1 other ancestor5 generations back: 2 other ancestors 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 3 descendants4 generations forward: 3 descendants K150485 · AVERT Contrast Modulation System · Osprey Medical, Inc. · 2015K140425 · Contrast Modulation System · Osprey Medical, Inc. · 2014K131478 · Contrast Conservation System · Osprey Medical, Inc. · 2013K991103 · Modification to Acist CL 100H · Acist Medical Systems · 2000 · recalledK984058 · Acist Injector System, Model CL100 H · Acist Medical Systems · 1999K963982 · Acist Angiographic Injector · Invasatec · 1997K822536 · MARK V · Medrad, Inc. · 1982−50
  1. Root · 7 generations backK822536 MARK VMedrad, Inc. · 1982
  2. 6 generations backK963982 Acist Angiographic InjectorInvasatec · 1997
  3. 5 generations backK984058 Acist Injector System, Model CL100 HAcist Medical Systems · 1999
  4. 4 generations backK991103 Modification to Acist CL 100HAcist Medical Systems · 2000 · Recalled
  5. 3 generations backK131478 Contrast Conservation SystemOsprey Medical, Inc. · 2013
  6. 2 generations backK140425 Contrast Modulation SystemOsprey Medical, Inc. · 2014
  7. 1 generation backK150485 AVERT Contrast Modulation SystemOsprey Medical, Inc. · 2015
  8. This deviceK151300 AVERT Contrast Modulation SystemOsprey Medical, Inc. · 2015
  9. Descendant · cites it directly · 7 of its ownK153141 DyeVert Contrast Modulation SystemOsprey Medical, Inc. · 2016
  10. Descendant · 2 generations on · 6 of its ownK161505 DyeVert NG Contrast Modulation SystemOsprey Medical, Inc. · 2016
  11. Descendant · 3 generations on · 5 of its ownK163054 DyeVert Plus Contrast Modulation/Monitoring System, Contrast…Osprey Medical, Inc. · 2017
  12. Descendant · 4 generations on · 2 of its ownK181936 DyeVert PLUS EZ Contrast Reduction SystemOsprey Medical, Inc. · 2018
  13. Descendant · 4 generations on · 1 of its ownK171698 Smart SyringeOsprey Medical, Inc. · 2017

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2016: 22017: 32018: 22019: 1
2016high 3 (2017) · low 0 (2020)2026

Most influential descendants

Showing 5 of 8 · See all
  • K153141DyeVert Contrast Modulation SystemOsprey Medical, Inc. · 2016 · cites it directly7descendants
  • K161505DyeVert NG Contrast Modulation SystemOsprey Medical, Inc. · 2016 · 2 generations on6descendants
  • K163054DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring SystemOsprey Medical, Inc. · 2017 · 3 generations on5descendants
  • K181936DyeVert PLUS EZ Contrast Reduction SystemOsprey Medical, Inc. · 2018 · 4 generations on2descendants
  • K171698Smart SyringeOsprey Medical, Inc. · 2017 · 4 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K822536MARK VMedrad, Inc.1982—
−6K963982Acist Angiographic InjectorInvasatec1997—
−5K984058Acist Injector System, Model CL100 HAcist Medical Systems1999—
−4K991103Modification to Acist CL 100HAcist Medical Systems20003
−3K131478Contrast Conservation SystemOsprey Medical, Inc.2013—
−2K140425Contrast Modulation SystemOsprey Medical, Inc.2014—
−1K150485AVERT Contrast Modulation SystemOsprey Medical, Inc.2015—
0 (this device)K151300AVERT Contrast Modulation SystemOsprey Medical, Inc.2015—
+1K153141DyeVert Contrast Modulation SystemOsprey Medical, Inc.2016—
+2K161505DyeVert NG Contrast Modulation SystemOsprey Medical, Inc.2016—
+3K163054DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring SystemOsprey Medical, Inc.2017—
+4K181936DyeVert PLUS EZ Contrast Reduction SystemOsprey Medical, Inc.2018—
+4K171698Smart SyringeOsprey Medical, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199610
199910
200020
200510
201110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201620
201730
201820
201910
FIG. 1 — Lineage of K151300, 1982–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXT device

  1. #1 K253048 High Pressure Syringe; Pressure Connecting…score 13.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140425Contrast Modulation System
Summary page 5
…nd Syringe, Angiographic Classification Registration: 21 CFR § 870.1650 Product Code: DXT 510(k) number(s) K140425, K150485 Comparison to the Predicate Device: The AVERT Contrast Modulation System is substantially equivalent to the previously…
Osprey Medical, Inc.2014—
*K150485AVERT Contrast Modulation System
Summary page 5
…e, Angiographic Classification Registration: 21 CFR § 870.1650 Product Code: DXT 510(k) number(s) K140425, K150485 Comparison to the Predicate Device: The AVERT Contrast Modulation System is substantially equivalent to the previously cleared…
Osprey Medical, Inc.2015—

Also cleared against K140425: 3 other devices →

What descends from it? (8)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K153141DyeVert Contrast Modulation SystemOsprey Medical, Inc.20167

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 33 years and passes through 4 companies; a new generation was cleared every 1.2 years on median.
  • 3 of the 14 ancestors have a recall of any class.
  • Of its descendants, K153141 (Osprey Medical, Inc., 2016) has gone furthest, with 7 descendants of its own.
  • 3 other devices also cite its predicate K140425.

How does its category compare?

All DXT devices

DXT Injector And Syringe, Angiographic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · DXT

1in 2025

2007: 32008: 22009: 62010: 12011: 42013: 22014: 62015: 72016: 82017: 72018: 92019: 42020: 32021: 12023: 12024: 42025: 12026 (partial year): 7
2007high 9 (2018) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXT

138in 2024

2007: 182 days median2009: 137 days median2011: 69 days median2014: 144 days median2015: 153 days median2016: 172 days median2017: 183 days median2018: 93 days median2019: 96 days median2020: 154 days median2024: 138 days median2026 (partial year): 264 days median
2007high 264 (2026) · low 69 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXT

10in 2024

2007: 42008: 32009: 72010: 32011: 32012: 72015: 12018: 22020: 12021: 12023: 22024: 102026 (partial year): 6
2007high 10 (2024) · low 0 (2013)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXT

97in 2025

2007: 1072008: 1682009: 1882010: 1242011: 1332012: 1352013: 1412014: 972015: 1352016: 1522017: 1282018: 1292019: 1212020: 932021: 1322022: 1112023: 1172024: 1182025: 97
2007high 188 (2009) · low 93 (2020)2025

MAUDE reports naming product code DXT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200731824107
20082—3168
200961377188
20101—3124
20114693133
20120—7135
20132—0141
20146144097
201571531135
201681720152
201771830128
20189932129
20194960121
20203154193
20211—1132
20220—0111
20231—2117
2024413810118
20251—097
202672646—

What is it indicated for?

The Osprey Medical AVERT™ System allows for controlled infusion and contrast volume reduction during manual injection of radiopaque contrast media. The AVERT™ System is to be used for angiographic coronary and peripheral procedures with the following agents: Iodixanol 270 or 320 mgI/ml, Iohexol 300 or 350 mgI/ml, and Iopamidol 300 or 370 mgI/ml.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151300: AVERT Contrast Modulation System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151300

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026